Over 200 participants attended the 2nd Annual Henry Ford Health + Michigan State University Health Sciences Cancer Research Symposium.
The two-day partnership event held in Detroit, Mich., focused on “Driving Innovations in Cancer Treatment and Prevention.” The program also featured a keynote address each day given by prominent cancer researchers Timothy Chan, M.D. from the Cleveland Clinic, and Michael Caligiuri, M.D. from the City of Hope.
“This research symposium allowed scientists from both institutions a platform to highlight their research,” said Ben Rybicki, Ph.D., Henry Ford Health researcher and symposium planning committee co-chair. “More importantly, it provided an avenue for networking and critical initial discussions about new research collaborations.”
The collaboration included a poster session featuring the research of 50 different Henry Ford and MSU faculty and trainees. In addition, Henry Ford and MSU participants attended sessions that highlighted the partnership’s scientific strengths across four cancer research programmatic areas and six different cancer tumor types.
“These connections made at this two-day symposium will provide the impetus for building future collaborative research programs,” said Rybicki.